03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Dullarma 140mg : | |
Type | Medicine Authorised |
Originator | Imbruvica 140mg |
Agent | Droguerie Mercury |
Distributor | Droguerie Mercury |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | The Arab Pharmaceutical Manufacturing Co Ltd |
Origin | Jordan |
ATC | L01XE27 |
Dullarma 140mg :
Dullarma 140mg :
Dullarma 140mg :
Dullarma 140mg :
Dullarma 140mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Dullarma 140mg :
Dullarma 140mg :
Dullarma 140mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anaemia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Atrial fibrillation | Common |
Constipation | Very Common |
Contusion | Very Common |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Very Common |
Dry mouth (Xerostomia) | Common |
Epistaxis (Nasal bleeding) | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Haemorrhage | Very Common |
Headache | Very Common |
Hyperuricaemia | Common |
Leukocytosis | Common |
Leukostasis | Uncommon |
Lymphocytosis | Common |
Musculoskeletal pain | Very Common |
Nausea | Very Common |
Neutropenia | Very Common |
Oedema peripheral | Very Common |
Petechiae | Very Common |
Pneumonia | Very Common |
Pyrexia | Very Common |
Sepsis (Systemic infection) (Sepsis state) | Common |
Sinusitis | Very Common |
Skin infection | Very Common |
Skin rash | Very Common |
Stomatitis | Very Common |
Subdural haematoma | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Tumour lysis syndrome | Uncommon |
Upper respiratory tract infection | Very Common |
Urinary tract infection | Very Common |
Vision blurred | Common |
Vomiting | Very Common |
Dullarma 140mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Dullarma 140mg MoH 11623 :
Form | Capsule, hard |
Packaging | Bottle (HDPE) (high density polyethylene) |
Package Size | Box of 120 |
Strength | 140mg |
Public Price | 422860803.46 L.L. |
Stratum | E2 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 41523/1 |
Submission date | 09/05/2023 |
Registration Year | 13/06/2024 |
Price Comparison
● Country: | Lebanon | |
● Form: | Capsule, hard | |
● Package Size: | Box of 120 | |
● Public Price: | 422860803.46 LBP | ( 422,860,803.46 LBP ) |
● Pack size unit used: | 120 | |
● Cost/Unit: | 3523840,03 LBP | ( 3,523,840.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File